Fatal Fulminant Hepatic Failure in a Diabetic with Primary Dengue by Viswanathan, Stalin et al.
Hindawi Publishing Corporation
Journal of Tropical Medicine
Volume 2010, Article ID 413561, 3 pages
doi:10.1155/2010/413561
Case Report
FatalFulminantHepaticFailure ina Diabetic
withPrimary Dengue
StalinViswanathan,Nayyar Iqbal, P. PhilipAnemon, andG. ShyamKumar
Department of Medicine, Pondicherry Institute of Medical Sciences, Kalapet, Pondicherry 605014, India
Correspondence should be addressed to Stalin Viswanathan,stalinviswanathan@ymail.com
Received 30 September 2010; Accepted 13 December 2010
Academic Editor: Ib Christian Bygbjerg
Copyright © 2010 Stalin Viswanathanet al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
We report a 49-year-old diabetic with dengue hemorrhagic fever who developed fulminant hepatitis, severe coagulopathy, shock,
and refractory metabolic acidosis and died on the eighth day of illness. This is the only second report of an adult with fatal
fulminant hepatic failure due to dengue, and the ﬁrst case arising from a primary dengue infection.
1.Introduction
Dengue is an arboviral illness caused by four serotypes
(DEN-V 1 to 4) and is transmitted by the bite of an infected
Aedesmosquito with an incubation period varying from 3 to
14 days [1]. Hepatic failure in dengue has been frequently
reported in the pediatric population and is rare in adults
[2]. Fulminant hepatic failure has been reported only in six
adults as of 2007, one of whom, a Bangladeshi immigrant to
England, had had a fatal illness with secondary dengue [3].
We report a case of fulminant hepatic failure arising from
a primary dengue infection in a middle-aged diabetic that
ended in his death.
2.CaseReport
This 49-year-old bus driver was admitted with complaints
of fever, headache, bodyaches, nausea, and fatigue for 5
days prior to admission. He had been on oral hypoglycemic
agents for the previous three years and did not smoke and
was a teetotaler. Examination revealed a temperature of
100◦F, tachycardia (105/min), normotension, and tachypnea
(28/minute) in a tired and drowsy looking obese man (BMI-
32kg/m2). He had a palpable liver of 5cm and right-
sided pleural eﬀusion (Figure 1). Pending reports, he was
instituted on intravenous ceftriaxone and artesunate and
oral doxycycline. Investigations showed hemoconcentration,
thrombocytopenia, direct hyperbilirubinemia, transami-
nases elevation (aspartate transaminase/alanine transami-
nase (AST/ALT) = 2.3), prolonged activated partial throm-
boplastin time (aPTT) and prothrombin time, and prerenal
azotemia with hyperkalemia (Table 1). Dengue IgM and
NS1 antigen were positive, while malarial smear and scrub
IgM ELISA were negative. Hepatitis panel and HIV were
negative. Serum ceruloplasmin was normal. An abdominal
ultrasonogram (day 2) revealed hepatomegaly, gall bladder
edema, moderate ascites, and bilateral pleural eﬀusion.
An internal jugular central venous access was secured
following platelet transfusion, and intravenous ﬂuids (dex-
trose saline), fresh frozen plasma (FFP), intravenous vitamin
K and thiamine, lactulose, and oral metronidazole were
administered. Six hours after admission, he was intubated
and mechanically ventilated for worsening sensorium and
respiratory distress. Eleven hours after admission he devel-
oped shock,despite normal-to-high central venous pressures
and metabolic acidosis poorly responsive to noradrenaline,
dopamine, and bicarbonate infusions. His transaminase
levels continued to increase (AST > ALT = 5; Table 1),
and coagulation parameters could not be corrected despite
transfusion of packed cells (3 units) and FFP (14 units) over
42 hours of hospital stay which ended fatally for this man
with dengue hemorrhagic fever.2 Journal of Tropical Medicine
Figure 1: Chest radiograph on day 1 with right-sided pleural
eﬀusion.
Table 1: Laboratory values.
Parameter Day 1 Day2 Day 3
Hemoglobin g/dL 18.9 14.3 8.6
Hematocrit 51.8 42 27
Platelets/cumm 15000 9000 21000
Leukocyte/cumm 10700 20400
Urea (mg/dL) 49 59 63
Creatinine (mg/dL) 1.6 2.8 4.7
Total bilirubin (mg) 5.7 4.6
Direct bilirubin (mg) 3.1 3
Aspartate transaminaseU/L 8980 28050
Alanine transaminaseU/L 3850 5580
Alkaline phopshatase U/L 206 290
Total protein g/dL 6.4 5
Serum albumin g/dL 3.8 2.9
Creatine kinase U/L 46
aPTT prolongation(seconds) 46 75 47
Prothrombin time prolongation (seconds) 31 52 39
3.Discussion
Dengue hemorrhagic fever (DHF) is deﬁned by the presence
of fever, thrombocytopenia, hemorrhagic tendencies, and
evidence of capillary leak [4]. Dengue hemorrhagic fever
generally occurs in secondary infection of another serotype
and is more common in children, but studies in Thailand
have shown an increasing prevalence in adults; moreover,
an association with secondary infection seems less likely in
adults [4]. Case fatalities are highest in children, and in
developingcountries DHF has a mortality of 5% [5]. Studies
in travelers, na¨ ıve to the dengue virus, on returning from
endemic regions have shown a similar mortality in DHF to
that of people residing in endemic areas [4].
In DHF, an antibody-dependent immune mechanism is
in play, by which nonneutralizing antibodies of previous
dengue infection complexes with the new infecting serotype
enhancing its uptake [1]. Liver damage is due to viral
replication in hepatocytes, cytokine-related damage, and
partly due to ischemic hepatitis [6, 7], but in our patient,
with worsening hemodynamic parameters and necessity
of inotropic support, the bilirubin remained stable and
AST/ALT ratio did not reverse (Table 1). Also a dengue
virus-speciﬁc CD4+ and CD8+ T cells may cause cytolysis
[1]. The dengue virus targets both the hepatocyte as well
as kupﬀer cell and following internalization induces tumor
necrosis factor-related apoptotic damage [8]. The virus
enters the hepatocytes and kupﬀer cells by phagocytosis
andreceptor-mediatedendocytosis,respectively,[1].Dengue
characteristically causes zone 2 necrosis of the liver, and
the changes are similar to those of the yellow fever [8].
Liver biopsy usually reveals massive inﬁltration by the virus,
with minimal mononuclear cell inﬁltrate [9]. Other ﬁndings
include Councilman bodies, kupﬀer cell hyperplasia, and
steatosis [1].
Dengue can cause mild elevations in transaminases, but
the levels seen in our patient have not been previously
reported. Transaminases can be elevated ﬁve to ten times
the normal in DHF [6]. Acute hepatitis is more common
in dengue fever, while fulminant hepatic failure is more
common in DHF [6, 9]. Acute hepatitis is seen in less
than four percent of patients with dengue [10]. Aspartate
transaminase [AST] elevationis more commoner and higher
than ALT elevations, and this is similar to that of alcoholic
hepatitis [1, 8]. Transaminase elevations peak on the 7th
to 8th day [6]. ALT elevation at par with AST levels
generally reﬂects hepatic cell necrosis. Our patient had
AST/ALT of 8980/3850U/L at admission which increased to
28050/5580U/L on day 3 of hospitalization (day 8 of illness).
He also had thrombocytopenia of 15000/mm3 that fell to
9000/mm3 on day 2 without overt bleeding manifestations.
Jaundice and raised alkaline phosphatase have also been
observed in DHF as was seen in our patient [7]. Factors
which worsen liver disease in dengue include presence
of shock, acidosis, and preexisting alcoholic liver disease,
diabetes,hepatotoxicdruguse,sicklecelldisease,and race[6,
7]. Coexisting Hepatitis B infection does not seem to worsen
the prognosis although acetaminophen and antiemetic
usage may predilect to further liver damage [1]. Shock,
acidosis, severe thrombocytopenia, bleeding diathesis, and
encephalopathy were associated with mortality in dengue
[6, 10]. Dengue encephalopathy is associated with very high
levels of transaminases [8]. Our patient developed shock
requiringinotropesandhadrefractory metabolicacidosis;he
was ateetotalerbutwas anobesediabeticandmighthavehad
a component of nonalcoholic fatty liver disease. Serotypes
1 and 3 are more hepatotropic than the others although all
four serotypes can be associated with hepatic dysfunction
[6]. Also some serotypes may have more epidemic potential
than the others, and therefore they replicate faster leading
to higher levels of viremia [1]. We did not have facility for
serotype identiﬁcation in our hospital. In view of shock,
myocarditis and pancreatitis were ruled out by normal
levels of cardiac enzymes, amylase, lipase, and a bedside
echocardiography.
In conclusion, primary dengue can rarely cause fulmi-
nant hepatic failure and death, which may be prevented
by early and aggressive supportive measures that include
volume resuscitation, treatment of coagulopathy, acidosis,
and encephalopathy.Journal of Tropical Medicine 3
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